VONOPRAZAN-AMOXICILLIN DUAL THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY FOR TREATMENT OF HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Abosheaishaa, Hazem
Elsayed, Hesham
Harfoush, Mohamed K.
Abusuliman, Mohammed
Abdelhalim, Omar
Mohamed, Islam
Sethi, Arshia
El Haddad, Islam M.
Salem, Ahmed
Nassar, Mahmoud
Karna, Rahul
Bilal, Mohammad
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1384
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [21] Vonoprazan-Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial
    Qiu, Shuhan
    Huang, Yu
    Chen, Jinnan
    Guo, Yixian
    Li, Meixuan
    Ding, Zhaohui
    Liang, Xiao
    Lu, Hong
    HELICOBACTER, 2024, 29 (04)
  • [22] High-dose dual therapy versus bismuth-containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta-analysis
    Wang, Hui
    Kong, Qing Zhou
    Li, Yue Yue
    Yang, Xiao Yun
    Zuo, Xiu Li
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (03) : 163 - 175
  • [23] Guideline-based bismuth quadruple therapy for helicobacter pylori infection in China: A systematic review and network meta-analysis
    Wei, Jiali
    Zheng, Zehao
    Wang, Xin
    Jia, Boyi
    Sun, Mingyao
    Wang, Jiayi
    Wan, Qin
    Han, Mei
    Qiu, Yue
    PLOS ONE, 2025, 20 (02):
  • [24] Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol
    ShaoWei Han
    ZiJie Deng
    KaShing Cheung
    Tao Lyu
    PuiLing Chan
    Ying Li
    Li Ni
    XiaPeng Luo
    Kuan Li
    BMC Gastroenterology, 23
  • [25] Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori infection in China: a three-arm, randomised clinical trial protocol
    Han, ShaoWei
    Deng, ZiJie
    Cheung, KaShing
    Lyu, Tao
    Chan, PuiLing
    Li, Ying
    Ni, Li
    Luo, XiaPeng
    Li, Kuan
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [26] Meta-analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy
    Yang, Hui
    Zhang, Miao
    Ma, Gang
    Yang, Jiaqi
    Wang, Kemei
    Jiang, Shuangshuang
    Dong, Jiaqiang
    Han, Ying
    HELICOBACTER, 2024, 29 (02)
  • [27] Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication
    Horii, Toshiki
    Suzuki, Sho
    Takano, Chika
    Shibuya, Hitoshi
    Ichijima, Ryoji
    Kusano, Chika
    Ikehara, Hisatomo
    Gotoda, Takuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (12) : 3314 - 3321
  • [28] Ten-Day Vonoprazan-Amoxicillin Dual Therapy vs Standard 14-Day Bismuth-Based Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Multicenter Randomized Clinical Trial
    Yan, Tian-Lian
    Wang, Jing-Hua
    He, Xin-Jue
    Zhu, Ya-Bi
    Lu, Lin-Jie
    Wang, Yan-Jiao
    Wang, Zi-Wei
    Gao, Jian-Guo
    Xu, Cheng-Fu
    Ma, Han
    Luan, Shuang-Mei
    Li, Lan
    Chen, Yi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (04): : 655 - 661
  • [29] Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis
    Yao, Gaoyan
    Fan, Xiaoyuan
    Lu, Dewen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (10)
  • [30] Efficacy and safety of vonoprazan and high-dose amoxicillin dual therapy in eradicating Helicobacter pylori : A systematic review and meta-analysis
    Zhang, Ju
    Zhang, Huan
    Zhu, Xiao-Jing
    Yao, Nuo
    Yin, Ju-Mei
    Liu, Jian
    Dan, Han-Jun
    Pang, Qi-Meng
    Liu, Zhi-Hua
    Shi, Yong-Quan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (05)
12345